What is Aredia used for?

Aredia is indicated for Humoral hypercalcemia of malignancy, Osteitis deformans, Osteolytic Bone Metastases of Breast Cancer, Osteolytic Lesions of Multiple Myeloma.

What development phase is Aredia in?

Aredia is FDA-approved (marketed).

What is the generic name of Aredia?

PAMIDRONIC ACID is the generic (nonproprietary) name of Aredia.

Last reviewed 2026-04-20 · How we verify

Aredia (PAMIDRONIC ACID)

FDA-approved approved Small molecule Quality 36/100

At a glance

Generic name	PAMIDRONIC ACID
Drug class	Bisphosphonate
Target	Farnesyl pyrophosphate synthase
Modality	Small molecule
Therapeutic area	Oncology
Phase	FDA-approved
First approval	1991

Approved indications

Humoral hypercalcemia of malignancy
Osteitis deformans
Osteolytic Bone Metastases of Breast Cancer
Osteolytic Lesions of Multiple Myeloma

Common side effects

No common side effects on file.

Key clinical trials

Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results